Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cardiovascular disease news

Show

From To
Managing non-communicable diseases among people living with HIV

Non-communicable diseases (NCDs) – including cardiovascular diseases, diabetes, cancers, and other illnesses – will represent a significant challenge for HIV care in low- and middle-income countries as

Published
13 September 2016
By
Theo Smart
PEPFAR and AstraZeneca Launch Partnership Across HIV and Hypertension Services in Africa

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and biopharmaceutical company AstraZeneca today announced a $10 million (subject to the availability of funds), five-year global public-private partnership that will expand access to HIV/AIDS and hypertension services by offering them in an integrated manner at existing PEPFAR-supported HIV/AIDS sites, beginning in Kenya.

Published
12 September 2016
From
PEPFAR
Statins reduce risk of progression to cirrhosis in people with HIV/HCV co-infection

Treatment with statins decreases the risk of progression to liver cirrhosis in people with HIV and hepatitis C virus (HCV) co-infection, investigators from the United States report

Published
06 September 2016
By
Michael Carter
Depression increases risk of heart attack for adults with HIV

Major depression is associated with an increased risk of heart attack for middle-aged HIV-positive people, investigators from the United States report in JAMA Cardiology. Overall, presence of

Published
30 August 2016
By
Michael Carter
Elevated lipids associated with cognitive decline in middle-aged HIV-positive men doing well on ART

Elevated cholesterol and a gene associated with Alzheimer’s risk in the general population are both risk factors for cognitive decline in middle-aged HIV-positive people with a suppressed viral

Published
29 August 2016
By
Michael Carter
Poor kidney function associated with increased cardiovascular risk for people with HIV

Renal impairment is associated with an increased risk of cardiovascular disease (CVD) in HIV-positive individuals, according to data from a large observational cohort study published in the online

Published
18 August 2016
By
Michael Carter
START analysis looks at who benefits most from immediate HIV treatment

Starting antiretroviral therapy (ART) soon after HIV diagnosis led to better outcomes than delayed treatment in all population sub-groups in the START trial, researchers reported at the

Published
04 August 2016
By
Liz Highleyman
Not So Fast: Do people with HIV really experience accelerated aging?

Recent talk about HIV and aging has almost always been scary. A number of studies conclude that people living with HIV have so-called “accelerated aging”—meaning they will suffer heart attacks, strokes, cancers, and osteoporosis more often and sooner than those without HIV. Well, this is one article on aging and HIV that will challenge the concept of people living with HIV having an early expiration date. Instead, we can look at what we know and what we don’t, to get a better idea of what the risks are for HIV-positive people growing older—and what they can do about them.

Published
08 July 2016
From
Positively Aware
Antiretroviral therapy may not be enough to reduce HIV-associated arterial inflammation

Initiating antiretroviral therapy soon after diagnosis of an HIV infection did not prevent the progression of significant arterial inflammation in a small group of previously untreated patients.

Published
26 May 2016
From
Eurekalert Inf Dis
Hypertension in patients with HIV associated with obesity, fat loss and previous treatment with stavudine

Patients with HIV have a higher prevalence of hypertension than closely matched HIV-negative controls, investigators from the Netherlands report in the online edition of Clinical Infectious Diseases.

Published
13 May 2016
By
Michael Carter
← First12345...22Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close